py,
Are you a startup developing ways of combating cancer? Israel's MEDX Xelerator announced this week that it is scouting worldwide for "disruptive" products, ideas and unmet needs in interventional oncology – and has launched its first $1 million challenge.
Follow Israel Hayom on Facebook and Twitter
Why interventional oncology? According to MEDX Xelerator CEO Shai Policker, this is "one of the more rapidly growing fields expected to bring significant breakthroughs in cancer management and we want to support the brilliant minds behind the next generation of advances."
"If you are a physician, engineer, or entrepreneur with a great idea or a startup company that addresses an unmet clinical need in interventional oncology, then we invite you to participate in this exciting and important competition," Policker added.
Areas of consideration include, but are not limited to: Embolization techniques; ablation technologies; and treatment and procedural optimization. The accelerator said that "strong clinical unmet needs" without a solution and relevant ideas that do not fall into the above categories will be considered.
Winners will be selected by a panel of judges chaired by Professor Stephen B. Solomon, Chief Interventional Radiologist at the Cancer Institute of Memorial Sloan Kettering Cancer Center. The deadline to apply is Feb. 15, 2022 at midnight Eastern Time.
Solomon said he was excited to moderate the challenge.
"I look forward to a much needed innovation in the area of interventional oncology coming from the joint expertise of physicians and engineers," he said.
In addition to receiving up to $1 million in funding, winners will be invited to join MEDX as a portfolio company or as an XLab feasibility project and benefit from the incubator services it provides.
For more information and to apply, click here
Subscribe to Israel Hayom's daily newsletter and never miss our top stories!
